RxDoctor Payments Data

Uzma Chaudhry, MD

Urogynecology and Reconstructive Pelvic Surgery · Trenton, NJNPI 1013320936

Payments from drug & device makers

What this record shows

This record is dominated by education: $12,000 of the $13,827 with a category attached, or 86.8%. Intuitive Surgical accounts for 86.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $12,100 and has fallen 95.3% since, to $573 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,827in general payments, 2019–2025

Across 91 payments — averaging $151.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$12K
  • Coloplast$700
  • Medtronic$487
  • Sumitomo Pharma America, Inc.$197
  • Urovant Sciences Inc$170
  • Novartis$125
  • plus $128 from 3 others

What the payments were for

  • Food & beverage$1,82713%
  • Education$12,00087%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,827 in reported general payments places this provider in the 90th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.

See all urogynecology and reconstructive pelvic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$66,279
Medicare patients
136
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron154$133,165
MyrbetriqMirabegron26$22,539
MounjaroTirzepatide12$12,620
Estradiol155$7,624
Methenamine Hippurate36$1,299
Solifenacin Succinate43$1,214
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst64$661
CefuroximeCefuroxime Axetil11$107
Ciprofloxacin Hcl27$72
Ibuprofen25$71
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$65
Acetaminophen-CodeineAcetaminophen With Codeine12$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$197$133,165154 claims
Astellas Pharma US IncMyrbetriq$62$22,53926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.

Other urogynecology and reconstructive pelvic surgery in Trenton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →